Intensity Therapeutics In... (INTS)
2.79
0.19 (7.31%)
At close: Jan 15, 2025, 3:58 PM
2.76
-1.02%
After-hours Jan 15, 2025, 05:28 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -10.54M | -7.58M | -7.90M | -6.03M | -5.38M |
| Depreciation & Amortization | n/a | 179.04K | n/a | n/a | n/a |
| Stock-Based Compensation | 1.40M | 1.17M | 719.82K | 555.49K | 561.38K |
| Other Working Capital | -2.26M | 326.02K | 227.00K | 159.22K | 104.36K |
| Other Non-Cash Items | 2.57M | 179.04K | 172.11K | 116.83K | 95.21K |
| Deferred Income Tax | n/a | -179.04K | n/a | n/a | n/a |
| Change in Working Capital | -633.00K | 756.69K | 176.80K | -12.03K | 306.91K |
| Operating Cash Flow | -7.21M | -5.48M | -6.83M | -5.37M | -4.42M |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -15.05M | n/a | n/a | -10.90M | -7.07M |
| Sales Maturities Of Investments | 9.03M | n/a | n/a | 15.46M | 8.77M |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -6.02M | n/a | n/a | 4.56M | 1.70M |
| Debt Repayment | 230.00K | 2.25M | 2.00M | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -2.18M | n/a | 50.00K | 6.29M | 3.86M |
| Financial Cash Flow | 20.47M | 2.25M | 2.05M | 6.29M | 3.86M |
| Net Cash Flow | 7.24M | -3.23M | -4.78M | 5.49M | 1.14M |
| Free Cash Flow | -7.21M | -5.48M | -6.83M | -5.37M | -4.42M |